Hostname: page-component-cd9895bd7-jn8rn Total loading time: 0 Render date: 2024-12-18T20:44:15.194Z Has data issue: false hasContentIssue false
  • English
  • Français

Nutrition and immune function in human immunodeficiency virus infection

Published online by Cambridge University Press:  28 February 2007

Derek C. Macallan
Derek C. Macallan*
Affiliation:
Division of Infectious Diseases, St George’s Hospital Medical School, Cranmer Terrace, London SW17 0RE, UK
*
Corresponding Author: Dr D. C. Macallan, fax +44 (0)181 725 3487, email [email protected]
Rights & Permissions [Opens in a new window]

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

The triad of human immunodeficiency virus (HIV) infection, nutritional status and immune function are intimately related, each factor having effects on the others. The dominant effect in this three-way relationship is the effect of HIV infection on nutritional status, an effect which, until the advent of potent anti-retroviral drugs, has been manifest primarily as wasting. Recently, more complex metabolic abnormalities have become apparent, particularly fat redistribution syndromes, hyperlipidaemia and hypercholesterolaemia. For the converse effect, the effect of nutritional state on HIV disease progression, there is good evidence that clinical outcome is poorer in individuals with compromised nutrition. However, the beneficial effects of nutritional support have been more difficult to demonstrate. For macronutrients, effective macronutrient supply improves survival in severely-malnourished individuals and may have beneficial effects in less-severely-affected individuals. Micronutrient deficiencies appear to be involved in modifying clinical HIV disease and may also be associated with enhanced mother-to-child transmission of virus, particularly in developing countries. Intervention trials in this setting are currently under way. In conclusion, the interaction of HIV infection and nutrition is of great importance not just because of the major impact that HIV infection has on nutritional state, but also because strategies to improve nutritional status, both quantitatively and qualitatively, may have a beneficial effect on the clinical and immunological course of the disease.

Keywords

HIV infectionAIDSNutritional statusWastingMicronutrients
Type
Symposium on ’Nutrition, infection and immunity‘
Information
Proceedings of the Nutrition Society , Volume 58 , Issue 3 , August 1999 , pp. 743 - 748
Copyright
Copyright © The Nutrition Society 1999

References

Baum, MK, Shor-Posner, G, Lu, Y, Rosner, B, Sauberlich, HE, Fletcher, MA, Szapocznik, J, Eisdorfer, C, Buring, JE & Hennekens, CH (1995) Micronutrients and HIV-1 disease progression. AIDS 9, 1051–1056.CrossRefGoogle ScholarPubMed
Behrens, G, Schmidt, H, Meyer, D, Stoll, M & Schmidt, RE (1998) Vascular complications associated with use of HIV protease inhibitors. Lancet 351, 1958.CrossRefGoogle ScholarPubMed
Carbonnel, F, Maslo, C, Beaugerie, L, Carrat, F, Wirbel, E, Aussel, C, Gobert, JG, Girard, PM, Gendre, JP, Cosnes, J & Rozenbaum, W (1998) Effect of indinavir on HIV-related wasting. AIDS 12, 1777–1784.CrossRefGoogle ScholarPubMed
Carr, A, Samaras, K, Burton, S, Law, M, Freund, J, Chisholm, DJ & Cooper, DA (1998 a) A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors. AIDS 12, F51–F58.CrossRefGoogle ScholarPubMed
Carr, A, Samaras, K, Chisholm, DJ & Cooper, DA (1998 b) Pathogenesis of HIV-1-protease inhibitor-associated peripheral lipodystrophy, hyperlipidaemia, and insulin resistance. Lancet 351, 1881–1883.CrossRefGoogle ScholarPubMed
Centers for Disease Control (1987) Revision of the CDC case surveillance definition for acquired immunodeficiency syndrome. Mortality and Morbidity Weekly Review 36, Suppl. 1S, 3S–14S.Google Scholar
Chandra, RK (1991) Nutrition and immunity: lessons from the past and new insights into the future. American Journal of Clinical Nutrition 53, 1087–1101.CrossRefGoogle ScholarPubMed
Chandra, RK (1997) Nutrition and the immune system: an introduction. American Journal of Clinical Nutrition 66, 460S–463S.CrossRefGoogle ScholarPubMed
Fawzi, WW, Msamanga, GI, Spiegelman, D, Urassa, EJ, McGrath, N, Mwakagile, D, Antelman, G, Mbise, R, Herrera, G, Kapiga, S, Willett, W & Hunter, DJ (1998) Randomised trial of effects of vitamin supplements on pregnancy outcomes and T cell counts in HIV-1-infected women in Tanzania. Lancet 351, 1477–1482.CrossRefGoogle Scholar
Force, G, Jockey, C, Tugler, MH, Khayat, G & Champetier de Ribes, D (1997) Characteristics of change in body composition with efficiency of antiretroviral treatment in AIDS patients. Nutrition 13, 290.CrossRefGoogle Scholar
Gallet, B, Pulik, M, Genet, P, Chedin, P & Hiltgen, M (1998) Vascular complications associated with use of HIV protease inhibitors. Lancet 351, 1958–1959.CrossRefGoogle ScholarPubMed
Greenberg, BL, Semba, RD, Vink, PE, Farley, JJ, Sivapalasingam, M, Steketee, RW, Thea, DM & Schoenbaum, EE (1997) Vitamin A deficiency and maternal-infant transmissions of HIV in two metropolitan areas in the United States. AIDS 11, 325–332.CrossRefGoogle ScholarPubMed
Grunfeld, C, Pang, M, Doerrler, W, Shigenaga, JK, Jensen, P & Feingold, KR (1992) Lipids, lipoproteins, triglyceride clearance, and cytokines in Human Immunodeficiency Virus infection and the Acquired Immunodeficiency Syndrome. Journal of Clinical Endocrinology and Metabolism 74, 1045–1052.Google ScholarPubMed
Hellerstein, MK, Grunfeld, C, Wu, K, Christiansen, M, Kaempfer, S, Kletke, C & Shackleton, CHL (1993) Increased de novo hepatic lipogenesis in human immunodeficiency virus infection. Journal of Clinical Endocrinology and Metabolism 76, 559–565.Google ScholarPubMed
Hellerstein, MK, Wu, K, McGrath, M, Faix, D, George, D, Shackleton, CH, Horn, W, Hoh, R & Neese, RA (1996) Effects of dietary n−3 fatty acid supplementation in men with weight loss associated with the acquired immune deficiency syndrome: Relation to indices of cytokine production. Journal of Acquired Immune Deficiency Syndrome and Human Retrovirology 11, 258–270.CrossRefGoogle ScholarPubMed
Henry, K, Melroe, H, Huebesch, J, Hermundson, J, Levine, C, Swensen, & Daley, J (1998 a) Severe premature coronary artery disease with protease inhibitors. Lancet 351, 1328.CrossRefGoogle ScholarPubMed
Henry, K, Melroe, H, Huebesch, J, Hermundson, J & Simpson, J (1998 b) Atorvastatin and gemfibrozil for protease-inhibitor-related lipid abnormalities. Lancet 352, 1031–1032.CrossRefGoogle ScholarPubMed
Hommes, MJT, Romijn, JA, Endert, E, Schattenkerk, JKME & Sauerwein, HP (1991 a) Basal fuel homeostasis in symptomatic human immunodeficiency virus infection. Clinical Science 80, 359–365.CrossRefGoogle ScholarPubMed
Hommes, MJT, Romijn, JA, Endert, E, Schattenkerk, JKME & Sauerwein, HP (1991 b) Insulin sensitivity and insulin clearance in Human Immunodeficiency Virus-infected men. Metabolism 40, 651–656.CrossRefGoogle ScholarPubMed
Kotler, DP, Tierney, AR, Wang, J & Pierson, RN (1989) Magnitude of body-cell-mass depletion and the timing of death from wasting in AIDS. American Journal of Clinical Nutrition 50, 444–447.CrossRefGoogle ScholarPubMed
Laurence, J (1998) Vascular complications associated with use of HIV protease inhibitors. Lancet 351, 1960.CrossRefGoogle ScholarPubMed
Lo, JC, Mulligan, K, Tai, VW, Algren, H & Schambelan, M (1998) ‘Buffalo hump’ in men with HIV-1 infection. Lancet 351, 867–870.CrossRefGoogle ScholarPubMed
Macallan, DC (1998) Metabolic abnormalities and wasting in human immunodeficiency virus infection. Proceedings of the Nutrition Society 57, 373–380.CrossRefGoogle ScholarPubMed
Macallan, DC, McNurlan, MA, Milne, E, Calder, AG, Garlick, PJ & Griffin, GE (1995 a) Whole body protein turnover from leucine kinetics and the response to nutrition in Human Immunodeficiency Virus infection. American Journal of Clinical Nutrition 61, 818–826.CrossRefGoogle ScholarPubMed
Macallan, DC, Noble, C, Baldwin, C, Foskett, M, McManus, T & Griffin, GE (1993) Prospective analysis of patterns of weight change in stage IV human immunodeficiency virus infection. American Journal of Clinical Nutrition 58, 417–424.CrossRefGoogle ScholarPubMed
Macallan, DC, Noble, C, Baldwin, C, Jebb, SA, Prentice, AM, Coward, WA, Sawyer, MB, McManus, TJ & Griffin, GE (1995 b) Energy expenditure and wasting in Human Immunodeficiency Virus infection. New England Journal of Medicine 333, 83–88.CrossRefGoogle ScholarPubMed
Melchior, JC, Gelas, P, Carbonnel, F, Zazzo, JF, Henzel, D, Cosnes, J, Bouletreau, P & Messing, B (1997) Improved survival by home Total Parenteral Nutrition in AIDS patients: Follow up of a controlled randomized prospective trial. Nutrition 13, 272 Abstr.CrossRefGoogle Scholar
Miller, KD, Jones, E, Yanovski, JA, Shankar, R, Feuerstein, I & Falloon, J (1998) Visceral abdominal fat accumulation associated with use of indinavir. Lancet 351, 871–875.CrossRefGoogle ScholarPubMed
Schwenk, A, Kremer, G, Cornely, O, Diehl, V, Fatkenheuer, G & Salzberger, B (1999) Body weight changes with protease inhibitor treatment in undernourished HIV infected patients. Nutrition 15, 453–457.CrossRefGoogle ScholarPubMed
Semba, RD, Miotti, PG, Chiphangwi, JD, Saah, AJ, Canner, JK, Dallabetta, GA & Hoover, DR (1994) Maternal vitamin A deficiency and mother-to-child transmission of HIV-1. Lancet 343, 1593–1597.CrossRefGoogle ScholarPubMed
Silva, M, Skolnik, PR, Gorbach, SL, Spiegelman, D, Wilson, IB, Fernandez-DiFranco, MG & Knox, TA (1998) The effect of protease inhibitors on weight and body composition in HIV-infected patients. AIDS 12, 1645–1651.CrossRefGoogle ScholarPubMed
Stricker, RB & Goldberg, B (1998) Weight gain associated with protease inhibitor therapy in HIV-infected patients. Research in Virology 149, 123–126.CrossRefGoogle ScholarPubMed
Sullivan, AK, Feher, MD, Nelson, MR & Gazzard, BG (1998) Marked hypertriglyceridaemia associated with ritonavir therapy. AIDS 12, 1393–1394.CrossRefGoogle ScholarPubMed
Suttmann, U, Ockenga, J, Selberg, O, Hoogestraat, L, Deicher, H & Muller, MJ (1995) Incidence and prognostic value of malnutrition and wasting in Human Immunodeficiency Virus-infected outpatients. Journal of Acquired Immune Deficiency Syndrome 8, 239–246.CrossRefGoogle ScholarPubMed
Tang, AM, Graham, NMH, Kirby, AJ, McCall, LD, Willett, WC & Saah, AJ (1993) Dietary micronutrient intake and risk of progression to Acquired Immunodeficiency Syndrome (AIDS) in Human Immunodeficiency Virus type 1 (HIV-1)-infected homosexual men. American Journal of Epidemiology 138, 937–951.CrossRefGoogle ScholarPubMed
Teixeira, A, Leu, JC, Honderlick, P, Trylesinski, A & Zucman, D (1997) Variation in body weight and plasma viral load in HIV patients treated with tritherapy including a protease inhibitor. Nutrition 13, 269 Abstr.CrossRefGoogle Scholar
Vittecoq, D, Escaut, L & Monsuez, JJ (1998) Vascular complications associated with use of HIV protease inhibitors. Lancet 351, 1959.CrossRefGoogle ScholarPubMed
Wheeler, DA, Gibert, CL, Launer, CA, Muurahainen, N, Elion, RA, Abrams, DI & Bartsch, GE (1998) Weight loss as a predictor of survival and disease progression in HIV infection. Terry Beirn Community Programs for Clinical Research on AIDS. Journal of Acquired Immune Deficiency Syndrome 18, 80–85.CrossRefGoogle ScholarPubMed